Chronically Radiation-Exposed Survivor Glioblastoma Cells Display Poor Response to Chk1 Inhibition under Hypoxia

Chronically Radiation-Exposed Survivor Glioblastoma Cells Display Poor Response to Chk1 Inhibition under Hypoxia

Glioblastoma is the most malignant primary brain tumor, and a cornerstone in its treatment is radiotherapy. However, tumor cells surviving after irradiation indicates treatment failure; therefore, better understanding of the mechanisms regulating radiotherapy response is of utmost importance. In thi...

Full description

Bibliographic Details
Main Authors:	Nareg Pinarbasi-Degirmenci, Ilknur Sur-Erdem, Vuslat Akcay, Yasemin Bolukbasi, Ugur Selek, Ihsan Solaroglu, Tugba Bagci-Onder
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Series:	International Journal of Molecular Sciences
Subjects:	glioblastoma radiotherapy radioresistance hypoxia DNA damage response Chk1
Online Access:	https://www.mdpi.com/1422-0067/23/13/7051

Similar Items

Tumor Cell Infiltration into the Brain in Glioblastoma: From Mechanisms to Clinical Perspectives
by: Fidan Seker-Polat, et al.
Published: (2022-01-01)

Editorial: Regulation and dysfunction of CSK and CHK
by: Shudong Zhu, et al.
Published: (2023-07-01)

Regulation, targets and functions of CHK
by: Shudong Zhu, et al.
Published: (2022-12-01)

Natural products targeting the ATR-CHK1 signaling pathway in cancer therapy
by: Salman Ahmed, et al.
Published: (2022-11-01)

Functions and inhibitors of CHK1 in cancer therapy
by: Kailong Jiang, et al.
Published: (2024-06-01)

AR phosphorylation and CHK2 kinase activity regulates IR-stabilized AR–CHK2 interaction and prostate cancer survival
by: Huy Q Ta, et al.
Published: (2020-06-01)

Blocking CHK1 Expression Induces Apoptosis and Abrogates the G2 Checkpoint Mechanism
by: Yan Luo, et al.
Published: (2001-01-01)

CHK2 Promotes Anoikis and is Associated with the Progression of Papillary Thyroid Cancer
by: Wenjing Zhao, et al.
Published: (2018-02-01)

CHK Methylation Is Elevated in Colon Cancer Cells and Contributes to the Oncogenic Properties
by: Shudong Zhu, et al.
Published: (2021-06-01)

Licochalcone A Suppresses the Proliferation of Osteosarcoma Cells through Autophagy and ATM-Chk2 Activation
by: Tai-Shan Shen, et al.
Published: (2019-07-01)

The Role of chk2 in Response to DNA Damage in Cancer Cells
by: Fereshteh Mir Mohammadrezaei
Published: (2015-03-01)

CHK2 Promotes Metabolic Stress-Induced Autophagy through ULK1 Phosphorylation
by: Ran Guo, et al.
Published: (2022-06-01)

Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ERα expression and proliferation in luminal primary and metastatic breast cancer cells
by: Sara Pescatori, et al.
Published: (2022-04-01)

The kinase domain residue serine 173 of Schizosaccharomyces pombe Chk1 kinase is critical for the response to DNA replication stress
by: Naomi Coulton, et al.
Published: (2017-12-01)

The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment
by: Ina Patties, et al.
Published: (2019-10-01)

SCFβ‐TrCP ubiquitinates CHK1 in an AMPK‐dependent manner in response to glucose deprivation
by: Ying Ma, et al.
Published: (2019-02-01)

Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma
by: Angélique Bruyer, et al.
Published: (2023-12-01)

STAU2 protein level is controlled by caspases and the CHK1 pathway and regulates cell cycle progression in the non-transformed hTERT-RPE1 cells
by: Lionel Condé, et al.
Published: (2021-03-01)

A novel role for the ROS-ATM-Chk2 axis mediated metabolic and cell cycle reprogramming in the M1 macrophage polarization
by: Chunlu Li, et al.
Published: (2024-04-01)

Sustained CHK2 activity, but not ATM activity, is critical to maintain a G1 arrest after DNA damage in untransformed cells
by: Iraia García-Santisteban, et al.
Published: (2021-02-01)

High-Content Screening of Eukaryotic Kinase Inhibitors Identify CHK2 Inhibitor Activity Against Mycobacterium tuberculosis
by: Tirosh Shapira, et al.
Published: (2020-09-01)

Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up‐regulation
by: Xiaoliang Zhao, et al.
Published: (2021-04-01)

Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
by: Andrea Ghelli Luserna Di Rorà, et al.
Published: (2019-10-01)

Targeting ATR/CHK1 pathway in acute myeloid leukemia to overcome chemoresistance
by: Laure David, et al.
Published: (2017-09-01)

Natural pentacyclic triterpenoid from Pristimerin sensitizes p53-deficient tumor to PARP inhibitor by ubiquitination of Chk1
by: Li Tao, et al.
Published: (2024-03-01)

Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine
by: Zay Yar Oo, et al.
Published: (2019-07-01)

Inhibition of Checkpoint Kinase 1 (CHK1) Upregulates Interferon Regulatory Factor 1 (IRF1) to Promote Apoptosis and Activate Anti-Tumor Immunity via MICA in Hepatocellular Carcinoma (HCC)
by: Xicai Li, et al.
Published: (2023-01-01)

Chk1 and the Host Cell DNA Damage Response as a Potential Antiviral Target in BK Polyomavirus Infection
by: Lydia E. Hainley, et al.
Published: (2021-07-01)

Radiation-induced Phosphorylation of Chk1 at S345 is Associated with p53-dependent Cell Cycle Arrest Pathways
by: Hui Tian, et al.
Published: (2002-01-01)

Involvement of DNA Damage Response via the Ccndbp1–Atm–Chk2 Pathway in Mice with Dextran-Sodium-Sulfate-Induced Colitis
by: Ryoko Horigome, et al.
Published: (2022-06-01)

Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer
by: Dufau Isabelle, et al.
Published: (2012-01-01)

Anti-Tumorigenic Activity of Chrysin from Oroxylum indicum via Non-Genotoxic p53 Activation through the ATM-Chk2 Pathway
by: Mai Nagasaka, et al.
Published: (2018-06-01)

The Combination of ATM and Chk1 Inhibitors Induces Synthetic Lethality in Colorectal Cancer Cells
by: Yuri Tozaki, et al.
Published: (2023-01-01)

An ATM-CHK2-INCENP pathway prevents chromatin breakage by regulating the abscission checkpoint
by: Eleni Petsalaki, et al.
Published: (2021-03-01)

Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer
by: Patrycja Gralewska, et al.
Published: (2020-04-01)

PKR-Mediated Phosphorylation of eIF2a and CHK1 Is Associated with Doxorubicin-Mediated Apoptosis in HCC1143 Triple-Negative Breast Cancer Cells
by: Sol Lee, et al.
Published: (2022-12-01)

Protective Effect of Follicle-Stimulating Hormone on DNA Damage of Chicken Follicular Granulosa Cells by Inhibiting CHK2/p53
by: Shuo Zhou, et al.
Published: (2022-04-01)

Cyclin D1 Binding Protein 1 Responds to DNA Damage through the ATM–CHK2 Pathway
by: Yusuke Niwa, et al.
Published: (2022-02-01)

Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets
by: Amalia Sofianidi, et al.
Published: (2024-03-01)

Duox-generated reactive oxygen species activate ATR/Chk1 to induce G2 arrest in Drosophila tracheoblasts
by: Amrutha Kizhedathu, et al.
Published: (2021-10-01)